These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8700793)
21. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845 [TBL] [Abstract][Full Text] [Related]
22. A nomogram for predicting optimal dosage of cyclosporine in renal transplant patients: taking physiological factors into consideration for regimen during immunosuppressive therapy. Shibata N; Hoshino N; Minouchi T; Yamaji A Biol Pharm Bull; 1995 Oct; 18(10):1423-9. PubMed ID: 8593449 [TBL] [Abstract][Full Text] [Related]
23. [Cyclosporine disposition in living related donor partial liver transplant recipients]. Tada A; Tsuboughi S; Zenda H; Matsunami H; Ikegami T; Hashikura Y; Kitahara S; Terada M; Ishizone S; Kawasaki S Yakugaku Zasshi; 1993 Jan; 113(1):84-93. PubMed ID: 8463960 [TBL] [Abstract][Full Text] [Related]
24. Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. Evans S; Michael R; Wells H; Maclean D; Gordon I; Taylor J; Goldsmith D Am J Kidney Dis; 2003 Feb; 41(2):493-6. PubMed ID: 12552515 [TBL] [Abstract][Full Text] [Related]
25. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients. Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719 [TBL] [Abstract][Full Text] [Related]
26. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation. Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863 [TBL] [Abstract][Full Text] [Related]
27. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone. Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676 [TBL] [Abstract][Full Text] [Related]
28. Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients. Nakamura T; Kakumoto M; Sakaeda T; Nagahiro K; Ohmichi R; Yamashita K; Nishiguchi K; Hirai M; Okumura K Biol Pharm Bull; 2001 Jun; 24(6):683-7. PubMed ID: 11411559 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group. Hoyer PF Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758 [TBL] [Abstract][Full Text] [Related]
35. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies. Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B. Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156 [TBL] [Abstract][Full Text] [Related]
37. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Egan LJ; Sandborn WJ; Tremaine WJ Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654 [TBL] [Abstract][Full Text] [Related]
38. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients. Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177 [TBL] [Abstract][Full Text] [Related]
39. Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation. Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Kato M; Sakai T; Takahashi M; Miura I Int J Clin Pharmacol Ther; 2012 Nov; 50(11):831-7. PubMed ID: 22943928 [TBL] [Abstract][Full Text] [Related]
40. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Erkko P; Granlund H; Nuutinen M; Reitamo S Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]